KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GSK) Invested Capital (2016 - 2025)

Gsk (GSK) has 9 years of Invested Capital data on record, last reported at $20.5 billion in Q4 2024.

  • For Q4 2024, Invested Capital rose 2.28% year-over-year to $20.5 billion; the TTM value through Dec 2024 reached $20.5 billion, up 2.28%, while the annual FY2024 figure was $20.4 billion, 1.65% up from the prior year.
  • Invested Capital reached $20.5 billion in Q4 2024 per GSK's latest filing, up from $20.0 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $47.0 billion in Q4 2021 and bottomed at $17.1 billion in Q4 2022.
  • Average Invested Capital over 5 years is $26.4 billion, with a median of $20.5 billion recorded in 2024.
  • Peak YoY movement for Invested Capital: surged 71.42% in 2021, then plummeted 63.72% in 2022.
  • A 5-year view of Invested Capital shows it stood at $27.4 billion in 2020, then soared by 71.42% to $47.0 billion in 2021, then plummeted by 63.72% to $17.1 billion in 2022, then rose by 17.43% to $20.0 billion in 2023, then grew by 2.28% to $20.5 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $20.5 billion in Q4 2024, $20.0 billion in Q4 2023, and $17.1 billion in Q4 2022.